A STAT Investigation

A STAT Investigation By Hyacinth Empinado and Usha Lee McFarling

Watch: A rebel with a cause: As a mentor and a leader, this Black orthopedic surgeon fights to diversify his field

A STAT Investigation By Usha Lee McFarling

Orthopedic surgeons pride themselves on fixing things. Can they fix their own field’s lack of diversity?

A STAT Investigation By Usha Lee McFarling

The whitest specialty: As medicine strives to close its diversity gaps, one field remains a stubborn outlier

A STAT Investigation By Rachel Cohrs

How America’s largest Catholic hospital system is moonlighting as a private equity firm

A STAT Investigation By Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

A STAT Investigation By Olivia Goldhill

‘In their own bubble’: How a cancer center promoted an exclusive experimental drug to attract patients

By Casey Ross and Erin Brodwin

‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans

A STAT Investigation By Kathleen McLaughlin

HHS relaxed oversight of problematic Covid-19 tests despite being told of accuracy concerns

A STAT Investigation By Casey Ross

From a small town in North Carolina to big-city hospitals, how software infuses racism into U.S. health care

Hydroxychloroquine at Rock Canyon Pharmacy

Politics By Lev Facher

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

A STAT Investigation By Casey Ross and Erin Brodwin

Hospitals turn to big tech companies to store and analyze their data — leaving patients in the dark on privacy protections

A STAT Investigation By Megan Thielking

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits

Politics By Talia Bronshtein

Nerd’s notes: How we did the ClinicalTrials.gov data analysis

A STAT Investigation By Charles Piller and Talia Bronshtein

Faced with public pressure, research institutions step up reporting of clinical trial results

Exclusive By Damian Garde

Biotech hedge fund titan Sam Isaly harassed, demeaned women for years, former employees say

A STAT Investigation By Ike Swetlitz and Casey Ross

Watch: A new advertising tack for hospitals: IBM’s Watson supercomputer is in the house

A STAT Investigation By Casey Ross and Ike Swetlitz

IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close

STAT + Boston Globe Investigation By David Armstrong — STAT and Evan Allen — Boston Globe

Behind the luxury: Turmoil and shoddy care inside five-star addiction treatment centers

A STAT Investigation By Sheila Kaplan

Failure to warn: An early warning system for drug risks falls flat

A STAT Investigation By Charles Piller

Most Read

Inside the downfall of longevity crusader Aubrey de Grey — and the cult of personality that concealed a pattern of harassment

Epic’s sepsis algorithm is going off the rails in the real world. The use of these variables may explain why

‘Health equity tourists’: How white scholars are colonizing research on health disparities

Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients

Cement Head’s last fight: He was denied parole six times — until he was about to become a Covid-19 statistic

Inside the fall of Watson Health: How IBM’s audacious plan to ‘change the face of health care’ with AI fell apart

Could AI tools for breast cancer worsen disparities? Patchy public data in FDA filings fuel concern

As the FDA clears a flood of AI tools, missing data raise troubling questions on safety and fairness

All Coverage